CYCLOSPORINE MONITORING

被引：12

作者：

BURCKART, GJ

CANAFAX, DM

YEE, GC

机构：

[1] UNIV MINNESOTA,PHARM,MINNEAPOLIS,MN 55455

[2] FRED HUTCHINSON CANC RES CTR,DIV CLIN RES,SEATTLE,WA 98104

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1986年 / 20卷 / 09期

关键词：

D O I：

10.1177/106002808602000901

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：649 / 652

页数：4

共 30 条

[1] BARRETT AJ, 1982, BRIT MED J, V285, P162, DOI 10.1136/bmj.285.6336.162
[2] BENNETT MJ, 1984, CLIN CHEM, V30, P817
[3] BLASCHKE Terence F., 1985, GOODMAN GILMANS PHAR, P49
[4] CYCLOSPORINE - EXPERIENCE WITH THERAPEUTIC MONITORING
BOWERS, LD
CANAFAX, DM
[J]. THERAPEUTIC DRUG MONITORING, 1984, 6 (02) : 142 - 147
[5] BOWERS LD, 1985, AM ASS CLIN CHEM, V7, P1
[6] BURCKART G, 1985, TRANSPLANT P, V17, P1172
[7] CYCLOSPORINE PHARMACOKINETICS AND BLOOD LEVEL MONITORING
BURKLE, WS
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (02): : 101 - 105
[8] CANAFAX DM, 1983, CLIN PHARMACY, V2, P515
[9] CANAFAX DM, 1985, TRANSPLANT P, V17, P1176
[10] CYCLOSPORINE AS PROPHYLAXIS FOR GRAFT-VERSUS-HOST DISEASE - A RANDOMIZED STUDY IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA
DEEG, HJ
STORB, R
THOMAS, ED
FLOURNOY, N
KENNEDY, MS
BANAJI, M
APPELBAUM, FR
BENSINGER, WI
BUCKNER, CD
CLIFT, RA
DONEY, K
FEFER, A
MCGUFFIN, R
SANDERS, JE
SINGER, J
STEWART, P
SULLIVAN, KM
WITHERSPOON, RP
[J]. BLOOD, 1985, 65 (06) : 1325 - 1334